Cargando…

1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020

BACKGROUND: In the US, approximately 60% of antimicrobial prescriptions (Rx) are written in the outpatient setting, and roughly 30% of those are unnecessary. The Tennessee Department of Health (TDH) previously described outpatient antimicrobial use in 2016 and 2018. TDH acquired additional data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouedraogo, Youssoufou, Evans, Christopher D, Wilson, Christopher, Staub, Milner B, Katz, Sophie E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752472/
http://dx.doi.org/10.1093/ofid/ofac492.1410
_version_ 1784850731945164800
author Ouedraogo, Youssoufou
Evans, Christopher D
Wilson, Christopher
Staub, Milner B
Katz, Sophie E
author_facet Ouedraogo, Youssoufou
Evans, Christopher D
Wilson, Christopher
Staub, Milner B
Katz, Sophie E
author_sort Ouedraogo, Youssoufou
collection PubMed
description BACKGROUND: In the US, approximately 60% of antimicrobial prescriptions (Rx) are written in the outpatient setting, and roughly 30% of those are unnecessary. The Tennessee Department of Health (TDH) previously described outpatient antimicrobial use in 2016 and 2018. TDH acquired additional data from the IQVIA Longitudinal Prescription and Medical Claims datasets. We sought to link antimicrobial Rx to diagnosis claims from preceding outpatient office visits to measure appropriateness of statewide antimicrobial Rx. METHODS: IQVIA medical claims data and antimicrobial Rx data for calendar year 2020 were used in this study. A unique patient ID was used to track antimicrobial Rx over time. Prescriptions filled within 7 days after a patient’s medical visit were included. Diagnoses codes from the medical visits were categorized as Tier 1 (diagnoses that always require antimicrobial therapy) and Tier 3 (diagnoses that never require antimicrobial therapy). Tier 2 diagnoses were excluded. We compared Tier 1 prescriptions versus Tier 3 Rx volume. RESULTS: We identified 2.3 million Rx linked to a preceding outpatient office visit within 7 days; 70.5% were filled within 3 days of the corresponding office visit, 14.1% within 4–5 days, and 15.4% within 6–7 days. Of all included Rx, 16.4% were prescribed following a pure Tier 1 diagnosis, and 83.6% were prescribed following a pure Tier 3 diagnosis. Diagnoses for respiratory conditions accounted for 38.4% of the pure Tier 3 visits, urinary tract conditions for 17.7%, gastrointestinal conditions for 16.2%, and skin and soft tissue conditions for 15.8%. For the respiratory conditions, viral upper respiratory infection accounted for the highest percent of antimicrobials prescribed (27.1%), followed by asthma/allergy indications (17%), and bronchitis (8.9%). CONCLUSION: A significant number of antimicrobials prescribed in Tennessee in 2020 were able to be linked to office visit diagnosis codes. Most Rx were prescribed for indications that do not require antimicrobial therapy. Respiratory conditions accounted for the highest percentage of visits resulting in antimicrobial therapy that did not require treatment. Continued educational efforts and provider feedback of these data are planned to combat unnecessary overprescribing in Tennessee. DISCLOSURES: Milner B. Staub, MD, MPH, Gilead: Stocks/Bonds|Johnson & Johnson: Stocks/Bonds.
format Online
Article
Text
id pubmed-9752472
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97524722022-12-16 1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020 Ouedraogo, Youssoufou Evans, Christopher D Wilson, Christopher Staub, Milner B Katz, Sophie E Open Forum Infect Dis Abstracts BACKGROUND: In the US, approximately 60% of antimicrobial prescriptions (Rx) are written in the outpatient setting, and roughly 30% of those are unnecessary. The Tennessee Department of Health (TDH) previously described outpatient antimicrobial use in 2016 and 2018. TDH acquired additional data from the IQVIA Longitudinal Prescription and Medical Claims datasets. We sought to link antimicrobial Rx to diagnosis claims from preceding outpatient office visits to measure appropriateness of statewide antimicrobial Rx. METHODS: IQVIA medical claims data and antimicrobial Rx data for calendar year 2020 were used in this study. A unique patient ID was used to track antimicrobial Rx over time. Prescriptions filled within 7 days after a patient’s medical visit were included. Diagnoses codes from the medical visits were categorized as Tier 1 (diagnoses that always require antimicrobial therapy) and Tier 3 (diagnoses that never require antimicrobial therapy). Tier 2 diagnoses were excluded. We compared Tier 1 prescriptions versus Tier 3 Rx volume. RESULTS: We identified 2.3 million Rx linked to a preceding outpatient office visit within 7 days; 70.5% were filled within 3 days of the corresponding office visit, 14.1% within 4–5 days, and 15.4% within 6–7 days. Of all included Rx, 16.4% were prescribed following a pure Tier 1 diagnosis, and 83.6% were prescribed following a pure Tier 3 diagnosis. Diagnoses for respiratory conditions accounted for 38.4% of the pure Tier 3 visits, urinary tract conditions for 17.7%, gastrointestinal conditions for 16.2%, and skin and soft tissue conditions for 15.8%. For the respiratory conditions, viral upper respiratory infection accounted for the highest percent of antimicrobials prescribed (27.1%), followed by asthma/allergy indications (17%), and bronchitis (8.9%). CONCLUSION: A significant number of antimicrobials prescribed in Tennessee in 2020 were able to be linked to office visit diagnosis codes. Most Rx were prescribed for indications that do not require antimicrobial therapy. Respiratory conditions accounted for the highest percentage of visits resulting in antimicrobial therapy that did not require treatment. Continued educational efforts and provider feedback of these data are planned to combat unnecessary overprescribing in Tennessee. DISCLOSURES: Milner B. Staub, MD, MPH, Gilead: Stocks/Bonds|Johnson & Johnson: Stocks/Bonds. Oxford University Press 2022-12-15 /pmc/articles/PMC9752472/ http://dx.doi.org/10.1093/ofid/ofac492.1410 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Ouedraogo, Youssoufou
Evans, Christopher D
Wilson, Christopher
Staub, Milner B
Katz, Sophie E
1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020
title 1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020
title_full 1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020
title_fullStr 1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020
title_full_unstemmed 1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020
title_short 1780. Analysis of Appropriate Outpatient Prescriptions based on Diagnosis Codes, Tennessee, 2020
title_sort 1780. analysis of appropriate outpatient prescriptions based on diagnosis codes, tennessee, 2020
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752472/
http://dx.doi.org/10.1093/ofid/ofac492.1410
work_keys_str_mv AT ouedraogoyoussoufou 1780analysisofappropriateoutpatientprescriptionsbasedondiagnosiscodestennessee2020
AT evanschristopherd 1780analysisofappropriateoutpatientprescriptionsbasedondiagnosiscodestennessee2020
AT wilsonchristopher 1780analysisofappropriateoutpatientprescriptionsbasedondiagnosiscodestennessee2020
AT staubmilnerb 1780analysisofappropriateoutpatientprescriptionsbasedondiagnosiscodestennessee2020
AT katzsophiee 1780analysisofappropriateoutpatientprescriptionsbasedondiagnosiscodestennessee2020